The growth of the gastrointestinal diagnostics market is attributed to the increasing incidence of gastrointestinal disorders such as gastric infections, IBD, GERD, GI bleeding, and others.
The growth of the gastrointestinal diagnostics market is attributed to the increasing incidence of gastrointestinal disorders such as gastric infections, IBD, GERD, GI bleeding, and others. The market is further being driven by unhealthy eating habits coupled with a surge in obesity incidence and genetic factors that lead to GI diseases. Technological developments are creating an enhanced opportunity for automated gastrointestinal diagnostics and panels.
For instance, in May 2022, Qiagen announced the launch of CE approved automated syndromic testing QiaStat-Dx system, compatible with its gastrointestinal panel. The use of quick point-of-care diagnostic tests is rising owing to the convenience (ease of use) which is facilitating the launch of faster products to expedite the treatment. For instance, in April 2021, QuickNavi-H.pylori was launched by Otsuka Pharmaceutical Co., Ltd. which provides test results in 8 minutes.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39476
The global market is segmented based on test type, technology, application, and test location. Among test types, the GI panel test segment held the largest share in 2021, owing to its rising adoption in the testing of gastric infections such as C. difficile infections. The enhanced focus of companies on tests for infectious diseases is attributable to the rising number of cases. For instance, in March 2022, Hardy Diagnostics became the exclusive U.S. distribution partner for BioCode MDx-3000 which offers Gastrointestinal Pathogen Panel (GPP).
North America held the largest segment share in 2021 and is projected to maintain its dominance over the forecast period. The market growth of North America is attributed to, increasing awareness of gastrointestinal diseases, the high prevalence of GI disorders, and the presence of advanced healthcare infrastructure. Moreover, high movement and strategic initiatives of leading players in the region contribute to the region’s expansion.
Asia Pacific is likely to be the fastest growing region during the projected period. The growth of the region is driven by, the presence of a large patient pool and the increasing geriatric population in the region. Further, the presence of untapped market potential and increasing demand for cost-efficient diagnostic solutions is anticipated to expedite the region’s growth.
Key Players
- BIOMERIEUX
- F. Hoffmann-La Roche Ltd
- Abbott
- Beckman Coulter, Inc
- Siemens Healthineers AG
- DiaSorin S.p.A
- QIAGEN, Hologic, Inc
- Meridian Bioscience
Market Segmentation
- By Test Type
- Endoscopy, Blood test
- H. pylori test
- Calprotectin test
- Immunoglobulin A test
- Others
- By Technology
- PCR
- Microbiology
- ELISA
- Others
- By Application
- Infection
- Inflammatory Bowel Disease
- Gastroesophageal Reflux Disease (GERD)
- Cancer
- Others
- By Test Location
- Central laboratories
- Point-of-Care
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39476
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333